Bastide Groupe: BASTIDE: 2023-2024 half-yearly results: Organic growth up 5.7%, EBITDA up 7.5%, Increase in recurring operating profit despite the inflationary context and margin of 8.3%. 2023-2024 outlook confirmed
Caissargues, March 20, 2024 In € millions - Year ended June 30 H1 2022-2023 H1 2023-2024 Change Revenue 249.7 265.0 +6.1 % EBITDA* 49.9 53.6 +7.5 % EBITDA margin 20.0% 20.2% Recurring operating pr...
Read full article »
Chairman & CEO
Vincent Bastide
Bastide as a group specializes in the rental and sale of medical devices.
Read more